These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6843035)

  • 1. [Bioavailability of trivalent iron contained in an oral preparation of iron III-hydroxide-dextrin complex].
    Heinrich HC; Fischer R; Gabbe EE; Theobald N
    Klin Wochenschr; 1983 Jan; 61(2):103-10. PubMed ID: 6843035
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of iron from oral ferric polymaltose in humans.
    Nielsen P; Gabbe EE; Fischer R; Heinrich HC
    Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Trivalent iron containing oral iron preparations.
    Heinrich HC
    Arzneimittelforschung; 1975 Jun; 25(6):975-6. PubMed ID: 1174335
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of bi- and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curves.
    Dietzfelbinger H
    Arzneimittelforschung; 1987 Jan; 37(1A):107-12. PubMed ID: 3566864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
    Geisser P; Müller A
    Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postpartum treatment of anemia with oral administration of an iron (III)-complex preparation].
    Drescher W; Miltenberg
    Med Welt; 1977 Jan; 28(2):88-90. PubMed ID: 840017
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron absorption from ferritin and ferric hydroxide.
    Derman DP; Bothwell TH; Torrance JD; Macphail AP; Bezwoda WR; Charlton RW; Mayet FG
    Scand J Haematol; 1982 Jul; 29(1):18-24. PubMed ID: 7123151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the therapeutic effects of trivalent and divalent iron in iron deficiency anaemia.
    Sas G; Nemesanszky E; Bräuer H; Scheffer K
    Arzneimittelforschung; 1984; 34(11):1575-9. PubMed ID: 6543133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the absorption of divalent and trivalent iron in living rats.
    Schäfer S; Forth W
    Arzneimittelforschung; 1984; 34(11):1570-4. PubMed ID: 6543132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioavailability of various iron preparations following oral medication].
    Heilmann E; Keim G
    Fortschr Med; 1980 Dec; 98(47-48):1871-4. PubMed ID: 7216093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of iron from ferric hydroxypyranone complexes.
    Maxton DG; Thompson RP; Hider RC
    Br J Nutr; 1994 Feb; 71(2):203-7. PubMed ID: 8142332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is ferric ion absorbed? Absorption of ferrous and ferric ions in healthy subjects and anemic patients].
    Heyder N; Waldherr A; Hartwich G
    Fortschr Med; 1982 Jul; 100(26):1259-61. PubMed ID: 7118034
    [No Abstract]   [Full Text] [Related]  

  • 15. Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man.
    Heinrich HC
    Arzneimittelforschung; 1987 Jan; 37(1A):105-7. PubMed ID: 3566863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical characterization of iron (III)-hydroxide-dextrin complexes. A comparative study of commercial preparations with alleged reproductions used in the examination of bioavailability.
    Erni I; Oswald N; Rich HW; Schneider W
    Arzneimittelforschung; 1984; 34(11):1555-9. PubMed ID: 6543130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the intravenous iron preparation Ferrlecit].
    Słomkowski M; Maj S
    Acta Haematol Pol; 1983; 14(1):49-53. PubMed ID: 6351527
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bioavailability of orally administered iron. Effects of alginate/antacid administration].
    Campo S; Breda E
    Minerva Med; 1992 Mar; 83(3):145-7. PubMed ID: 1553063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical contribution on the use of an iron polymaltosed oral preparation (intrafer)].
    Picchini F; Di Pietro M; Di Battista S; Moretti P; Celommi ML; Natali L; Ciarelli G; Bellocchio C; Di Battista C
    Minerva Pediatr; 1987 Sep; 39(17-18):729-33. PubMed ID: 3437863
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of oral iron(III) hydroxide polymaltose complex supplementation on hemoglobin increase, cognitive function, affective behavior and scholastic performance of adolescents with varying iron status: a single centre prospective placebo controlled study.
    Devaki PB; Chandra RK; Geisser P
    Arzneimittelforschung; 2009; 59(6):303-10. PubMed ID: 19634512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.